title: Immunotherapy of surgical malignancies.
authors.affiliation: Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Morse
authors.forename: H Kim
authors.initials: HK
authors.lastname: Lyerly
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Clay
authors.forename: Omar
authors.initials: O
authors.lastname: Abdel-Wahab
authors.forename: Stephen Y
authors.initials: SY
authors.lastname: Chui
authors.forename: Jennifer
authors.initials: J
authors.lastname: Garst
authors.forename: Jared
authors.initials: J
authors.lastname: Gollob
authors.forename: Peter M
authors.initials: PM
authors.lastname: Grossi
authors.forename: Matthew
authors.initials: M
authors.lastname: Kalady
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Mosca
authors.forename: Mark
authors.initials: M
authors.lastname: Onaitis
authors.forename: John H
authors.initials: JH
authors.lastname: Sampson
authors.forename: Hilliard F
authors.initials: HF
authors.lastname: Seigler
authors.forename: Eric M
authors.initials: EM
authors.lastname: Toloza
authors.forename: Douglas
authors.initials: D
authors.lastname: Tyler
authors.forename: Johannes
authors.initials: J
authors.lastname: Vieweg
authors.forename: Yiping
authors.initials: Y
authors.lastname: Yang
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000628:therapy; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007680:Kidney Neoplasms / Q000628:therapy; D008175:Lung Neoplasms / Q000628:therapy; D009369:Neoplasms / Q000276:immunology* / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome; D014611:Vaccination / Q000379:methods
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines